Skip to main content

Advertisement

Figure 1 | Diabetology & Metabolic Syndrome

Figure 1

From: Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practice

Figure 1

Changes in HBA1c and fasting blood glucose levels. A The reduction in HbA1c levels in the control (grey bars) and the active group (black bar) after 6–12 months of follow up. Least squares mean difference between the active and the control group 0.53 (0.31-0.76)%, p < 0.001. B The reduction in fasting blood glucose levels (FBG) in the control (grey bars) and the active group (black bar) after 6–12 months of follow up. Least squares mean difference between the active and the control group 27.85 (15.74-39.95) mg/dl, p < 0.001.

Back to article page